deferiprone has been researched along with MS (Multiple Sclerosis) in 3 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we aimed to investigate the possible contribution of ferroptosis in the demyelinated optic nerve, and to explore the effectiveness of ferroptosis inhibitor, deferiprone (DFP), on the extent of demyelination, inflammation and axonal damage." | 4.12 | Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve. ( Foolad, F; Heibatollahi, M; Javan, M; Khajeh, K; Rayatpour, A, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Rayatpour, A | 3 |
| Foolad, F | 3 |
| Heibatollahi, M | 3 |
| Khajeh, K | 3 |
| Javan, M | 3 |
| Khan, RS | 1 |
| Baumann, B | 1 |
| Dine, K | 1 |
| Song, Y | 1 |
| Dunaief, JL | 1 |
| Kim, SF | 1 |
| Shindler, KS | 1 |
| Weigel, KJ | 1 |
| Lynch, SG | 1 |
| LeVine, SM | 1 |
1 review available for deferiprone and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Iron chelation and multiple sclerosis.
Topics: Animals; Chelation Therapy; Deferiprone; Deferoxamine; Humans; Iron; Iron Chelating Agents; Multiple | 2014 |
2 other studies available for deferiprone and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve.
Topics: Animals; Deferiprone; Ferroptosis; Inflammation; Iron; Male; Mice; Mice, Inbred C57BL; Multiple Scle | 2022 |
Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve.
Topics: Animals; Deferiprone; Ferroptosis; Inflammation; Iron; Male; Mice; Mice, Inbred C57BL; Multiple Scle | 2022 |
Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve.
Topics: Animals; Deferiprone; Ferroptosis; Inflammation; Iron; Male; Mice; Mice, Inbred C57BL; Multiple Scle | 2022 |
Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve.
Topics: Animals; Deferiprone; Ferroptosis; Inflammation; Iron; Male; Mice; Mice, Inbred C57BL; Multiple Scle | 2022 |
Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve.
Topics: Animals; Deferiprone; Ferroptosis; Inflammation; Iron; Male; Mice; Mice, Inbred C57BL; Multiple Scle | 2022 |
Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve.
Topics: Animals; Deferiprone; Ferroptosis; Inflammation; Iron; Male; Mice; Mice, Inbred C57BL; Multiple Scle | 2022 |
Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve.
Topics: Animals; Deferiprone; Ferroptosis; Inflammation; Iron; Male; Mice; Mice, Inbred C57BL; Multiple Scle | 2022 |
Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve.
Topics: Animals; Deferiprone; Ferroptosis; Inflammation; Iron; Male; Mice; Mice, Inbred C57BL; Multiple Scle | 2022 |
Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve.
Topics: Animals; Deferiprone; Ferroptosis; Inflammation; Iron; Male; Mice; Mice, Inbred C57BL; Multiple Scle | 2022 |
Dexras1 Deletion and Iron Chelation Promote Neuroprotection in Experimental Optic Neuritis.
Topics: Animals; Chelating Agents; Deferiprone; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; | 2019 |